
%0 Journal Article
%T Psychometric properties of the Hypomania Checklist-32 in Korean patients with mood disorders
%J Clinical psychopharmacology and neuroscience
%D 2017
%A Yoon, Bo-Hyun
%A Angst, Jules
%A Bahk, Won-Myong
%A Wang, Hee Ryung
%A Bae, Seung-Oh
%A Kim, Moon-Doo
%A Jung, Young-Eun
%A Min, Kyung Joon
%A Lee, Hwang-Bin
%A Won, Seunghee
%A Hong, Jeongwan
%A Choi, Myong Su
%A Jon, Duk-In
%A Woo, Young Sup
%V 15
%N 4
%P 352-360
%X OBJECTIVE: The aim of this study was to examine the validity of the Korean version of the Hypomania Checklist-32, second revision (HCL-32-R2) in mood disorder patients. <br><br>METHODS: A total of 454 patients who diagnosed as mood disorder according to Structured Clinical Interview for DSM-IV Axis I Disorders, clinician version (SCID-CV) (bipolar disorder [BD] I, n=190; BD-II, n=72; and major depressive disorder [MDD], n=192) completed the Korean module of the HCL-32-R2 (KHCL-32-R2). <br><br>RESULTS: The KHCL-32-R2 showed a three-factorial structure (eigenvalue ＞2) that accounted for 43.26% of the total variance. Factor 1 was labeled "active/elated" and included 16 items; factor 2, "irritable/distractible" and included 9 items; and factor 3 was labeled "risk-taking/indulging" and included 9 items. A score of 16 or more on the KHCL-32-R2 total scale score distinguished between BD and MDD, which yielded a sensitivity of 70% and a specificity of 70%. MDD and BD-II also could be differentiated at a cut-off of 15 with maximized sensitivity (0.67) and specificity (0.66). Cronbach's alpha of KHCL-32-R2 and its subsets (factors 1, 2, and 3) were 0.91, 0.89, 0.81 and 0.79, respectively. Correlations between KHCL-32-R2 and Montgomery- Asberg Depression Rating Scale, Young Mania Rating Scale and Korean version of Mood Disorder Questionnaire were -0.66 (p=0.41), -0.14 (p=0.9), and 0.61 (p＜0.001), respectively. <br><br>CONCLUSION: The KHCL-32-R2 may be a useful tool in distinguishing between bipolar and depressive patients in clinical settings.<p /> <p>Language: en</p>
%G en
%I Korean College of Neuropsychopharmacology
%@ 1738-1088
%U http://dx.doi.org/10.9758/cpn.2017.15.4.352